Study suggests rationale for neoadjuvant PD-1 inhibitors in CRC subtype

Phase II study of personalized cancer vaccine in CRC shows positive preliminary PFS and long-term ctDNA data

The ongoing, signal-seeking phase II portion of the phase II/III study evaluating Granite, a personalized neoantigen cancer vaccine, in front-line metastatic microsatellite stable colorectal cancer, produced positive preliminary data.

April 05, 2024

Vol.50 No.14

In Brief

UVA, Southwest Virginia providers partner to boost CRC screening

The Community Health Center of the New River Valley and the University of Virginia Cancer Center partnered to boost southwest Virginia’s colorectal cancer screening rate by mailing at-home test kits to patients.

March 29, 2024

Vol.50 No.13

Clinical Roundup

Large USC study identifies genetic markers that may help explain link between red meat and colorectal cancer

A study led by USC Norris Comprehensive Cancer Center, part of the Keck School of Medicine of USC, analyzed data on red and processed meat intake from 29,842 people with colorectal cancer and 39,635 people without cancer.

March 22, 2024

Vol.50 No.12

Clinical

Multi-target FIT aims to offer inexpensive, high-sensitivity alternative to FIT in colorectal cancer screening

Developers of an investigational multi-target screening test for colorectal cancer and its precursors are aiming to replace the widely used conventional fecal immunochemical test.

March 01, 2024

Vol.50 No.09

By Matthew Bin Han Ong

Clinical Roundup

Study: Many don’t know alcohol, lack of exercise, high fat/processed foods are risk factors for colorectal cancer

A recent survey commissioned by the OSUCCC—James found that, while most U.S. adults identify family history (DNA-based risk passed down through families) as a risk factor for colorectal cancer, other factors such as alcohol use, lack of physical activity, and an American diet that is high in fat and processed foods were less known.

March 01, 2024

Vol.50 No.09

In Brief

OU Health Stephenson Cancer Center earns Center of Excellence for Rectal Cancer accreditation

OU Health Stephenson Cancer Center at the University of Oklahoma Health Sciences earned a three-year accreditation from the National Accreditation Program for Rectal Cancer, making it the only accredited program in Oklahoma and one of only three other accredited programs within a 500-mile radius to receive the accreditation from the quality program of the American College of Surgeons.

February 23, 2024

Vol.50 No.08

Study suggests rationale for neoadjuvant PD-1 inhibitors in CRC subtype

YOU MAY BE INTERESTED IN

Phase II study of personalized cancer vaccine in CRC shows positive preliminary PFS and long-term ctDNA data

UVA, Southwest Virginia providers partner to boost CRC screening

Large USC study identifies genetic markers that may help explain link between red meat and colorectal cancer

Multi-target FIT aims to offer inexpensive, high-sensitivity alternative to FIT in colorectal cancer screening

Study: Many don’t know alcohol, lack of exercise, high fat/processed foods are risk factors for colorectal cancer

OU Health Stephenson Cancer Center earns Center of Excellence for Rectal Cancer accreditation

Renew today!

Subscriber content

Login